Education
General vs Nongeneral Anesthesia for EVT in Patients With Large Core Strokes
This episode discusses the findings of a recent study comparing general versus non-general anesthesia in patients undergoing endovascular thrombectomy for large core strokes. Despite previous beliefs,...
General vs Nongeneral Anesthesia for EVT in Patients With Large Core Strokes
Education •
0:00 / 0:00
Interactive Transcript
spk_0
This is José Merino, Editor in Chief of the Neurology Family of journals.
spk_0
The neurology podcast provides practical information to neurologists and other clinicians to help
spk_0
them provide better care for their patients.
spk_0
Thanks for listening and have a great week.
spk_0
Hello everyone, this is Andy Sutherland from the University of Virginia and I'm very
spk_0
excited to be speaking with my friend and colleague, Emre Sarage, who is the George M. Humphrey
spk_0
II Chair and Professor of Neurology at Case Western Reserve School of Medicine and
spk_0
Director of the Comprehensive Stroke Center at University Hospitals Cleveland Medical
spk_0
Center.
spk_0
For this week's neurology podcast, we're going to be discussing an article recently published
spk_0
in the journal titled General Versus Non-Generally Anesthesia for Endovascular thrombectomy
spk_0
in patients with large, core strokes.
spk_0
I was pre-specified secondary analysis of the select two trial.
spk_0
The select two trial was a prospective randomized trial that should benefit of endovascular thrombectomy
spk_0
in patients with large, core, schema strokes defined by aspect score of three to five on non-contrast
spk_0
head CT or an scheme core greater than or equal to 50 milliliters on CT perfusion study.
spk_0
Primary trial results were published in New England Journal in 2023 and today we're going
spk_0
to be discussing the results of this pre-specified analysis comparing patients who received
spk_0
a general versus non-general anesthesia in the trial.
spk_0
So, Amru, always great to have you on the podcast.
spk_0
Thanks for joining us.
spk_0
Thank you so much, Andy.
spk_0
It's a pleasure to be with you.
spk_0
Fantastic for our audience who may not keep up with this literature day to day in the realm
spk_0
of vascular neurology, acute stroke treatment.
spk_0
There have been numerous prior studies, meta-analyses of clinical trials that look at this sort
spk_0
of question of method of anesthesia in patients undergoing endovascular therapy for large,
spk_0
muscle occlusion stroke.
spk_0
One might ask, why is it important to readdress this in the select two randomized trial of patients
spk_0
with large, schema strokes, and specifically those with large, schema cores prior to the
spk_0
procedure?
spk_0
What is the relevance that led you and your team to want to pre-specify this as an important
spk_0
analysis?
spk_0
We are all approaching and charted territory until two or three years ago.
spk_0
It was for long believe that patients with large, schema core, those with low aspects
spk_0
early schema changes on the CAT scan aspects of 5 or less and just in brief the aspect is
spk_0
a major for good imaging profile or poor imaging profile, small core or large core in patients
spk_0
presenting with large, muscle occlusion.
spk_0
The prior trials showed benefit in small core excluded patients largely with aspects of
spk_0
5 or less and the core is measured on the perfusion images, those were areas that studied
spk_0
in research before and showed that patients who have regional, surploplethtflow less than
spk_0
30% as compared to a normal territory would have irreversible schema changes when you
spk_0
follow them on MRI at 72 hours.
spk_0
So those patients were excluded from prior trials or excluded from our practice largely.
spk_0
They were not part of guidelines, they were not part of practice guidelines at the different
spk_0
facilities because of inherited beliefs that they will not benefit.
spk_0
Rightfully the risk and benefit for a school is not well established because you have patients
spk_0
with large horse.
spk_0
Unlikely they will do as a natural history but also the potential benefit is not high
spk_0
because they have large skirts just having any large am I, very large subarachnoid
spk_0
hemorrhage.
spk_0
Prognosis is not good and the risk of hemorrhage transformation is high because you are
spk_0
reperfusing large area of them far.
spk_0
So now as we studied those in this elective trial and showed benefit of thrombectomy
spk_0
in this population as other 5 trials, randomized trials across the world reported benefit, the
spk_0
tension trial in Germany and Europe and Canada, the angel aspects in China, the rescue
spk_0
jet band limit in Japan, the last day trial in France and finally the Tesla trial which
spk_0
also showed either benefit in 5 trials or same direction with their protocol benefit in
spk_0
Tesla.
spk_0
Now those patients became part of the practice.
spk_0
They are being treated guidelines, been changed and the Australian guidelines been changed.
spk_0
The American Heart Association hopefully soon as as far as I know this is in advanced stages.
spk_0
This has been guidelines included these patients with aspects of 3 to 5, 0 to 24 hours.
spk_0
So when these become part of our practice we need to know how to approach these patients
spk_0
and anesthesia is one of the important goals that is associated with the procedure should
spk_0
I put the patient under general anesthesia or should I treat them with local or conscious
spk_0
sedation.
spk_0
That's the first part, the second part, while we showed benefit in this population we
spk_0
and others, the outcomes remained not as good as we want them.
spk_0
By nature these patients have very large strokes, you are not expecting the 60-70%
spk_0
independence rate or modified rankings, kilo-zero to 2 at 90 days.
spk_0
We observe somewhere around 20% rate but it's better than medical management of around
spk_0
7%.
spk_0
We observed 40% independence mobility in the amount of 3 which is excellent outcome.
spk_0
40% of patients with very large infarms being able to walk independently at 90 days as
spk_0
compared to doubling this in medical management.
spk_0
But we want to optimize these outcomes.
spk_0
We want this 40% to become 50 and 60.
spk_0
We want this 20% with the independent independence to be 30 and 40%.
spk_0
So it's these and similarly variables.
spk_0
The anesthesia, the blood pressure, be it at junk to therapies and reducing the edema
spk_0
being hemicraniactomy or being devices in different procedure approaches.
spk_0
These are the and silery variables that would help us optimizing the outcomes.
spk_0
That's why we thought this would be an important question to should lie down.
spk_0
And that makes complete sense, not only as you point out where these patients more or
spk_0
less excluded from prior trials so it's hard to extrapolate anything from how they would
spk_0
do based on our prior trial experience.
spk_0
There are legitimate biological, physiologic reasons why people with large schemes,
spk_0
coars large strokes would respond differently to different methods of anesthesia, may have
spk_0
different degrees of variability in their vital sign management and so forth both during
spk_0
and after the procedure.
spk_0
So naturally it is a very important question to readdress.
spk_0
Getting right to it, what were the main findings from this substudy that you all recently
spk_0
published?
spk_0
We asked the question, would patients with constestation or with general anesthesia have
spk_0
better association with clinical outcomes after thrombectomy.
spk_0
So this is only in the thrombectomy of a relation not in the medical management population
spk_0
when compared to each other on the 90 day outcome.
spk_0
And overall we found no difference.
spk_0
There was no difference in the modified rank and scale which is the function of an outcome
spk_0
at 90 days and we looked at one year because we have one year in and select two, no difference
spk_0
in independent emulation between general anesthesia and constestation.
spk_0
As you may imagine patients who receive general anesthesia take longer time to start the procedures
spk_0
of thromb randomization to doing the growing puncture.
spk_0
It was longer and was statistically significant but it was not associated with worse outcome.
spk_0
There was no difference in infarct volume and we limited the population to only the patients
spk_0
who got successful reperfusion, Antiqui to be more and there was no difference and we
spk_0
tried to look at interaction with the collateral status, stroke severity, the aspect score,
spk_0
there was no interaction.
spk_0
And going back the reason why we would think that one would be different than the others
spk_0
and I would say I was one of the people who thought that especially in this population
spk_0
patients with constestation will do better.
spk_0
These are large pore patients and you are worried that by doing general anesthesia the blood
spk_0
pressure will drop and you will lose collaterals and you will make what's already a large
spk_0
and far at large so the patients will end up doing worse.
spk_0
That's the hypothesis when we asked the question and actually to be fair while we did not
spk_0
specify constestation versus general anesthesia in the protocol we recommend that the size
spk_0
would do constestation and because it's not mandatory the size went on and did what they
spk_0
did and that would be my message to people in practice of throrours we ended up with 60%
spk_0
of the patients received in general anesthesia.
spk_0
So people did what they wanted to do and they perked to be right because there was no association
spk_0
between the type of anesthesia and the outcome.
spk_0
And you bring up a good point there.
spk_0
It does allow some flexibility and practice in folks who really work in this one way or
spk_0
the other and I agree with you it is a ought to probably lean towards your hypothesis leading
spk_0
up to the results of the study but it wasn't randomized.
spk_0
People did do what they wanted to do and so there's some inherent selection bias in that.
spk_0
How do you think these results will affect current practice, have they affected your own practice.
spk_0
And then what are some of those key limitations that we should keep in mind as we're interpreting
spk_0
the results of the substudy?
spk_0
Sure.
spk_0
As you mentioned we did not randomized and that on that anesthesia type.
spk_0
There were trials randomized on that anesthesia type back a few years ago that believe
spk_0
it can was that constestation or result in better outcome.
spk_0
It started with subanalyses from the Hermes showing better outcomes with constestation or
spk_0
local anesthesia as compared to general anesthesia.
spk_0
Then the randomized trials, the CS10 and stroke showed no difference.
spk_0
The Goliath and individual patient data metane analysis of four anesthesia general versus non-general
spk_0
showed better outcome with general anesthesia.
spk_0
From the paper that we published from, select and extend IA in a neurology a few years ago,
spk_0
a general anesthesia was associated with worse outcome, higher neurological worsening and
spk_0
worse effect in colatolous and that's why we had both his eyes and that's why we recommended
spk_0
and select to that patient that people do conscious sedation.
spk_0
Why the results are different?
spk_0
This is a major point that people should take into their practice, should take into their research.
spk_0
There is a difference between causation and association.
spk_0
A lot of times and we saw this over and over in blood pressure management.
spk_0
You come and do a subanalysis of what a prospective study in that patient with lower blood pressure
spk_0
ended up doing worse or better.
spk_0
That's and then you come and say lower blood pressure resulted in improved out.
spk_0
It is association. It is not causal relationship and that's why the trials that did intensive
spk_0
blood pressure management actually showed that patients do worse with intensive blood pressure
spk_0
management. It's the same concept when it comes to this.
spk_0
What we are learning and what we learned that the effect of endovascular thrombectomy and
spk_0
the perfusion is pretty strong and overcomes a lot of the ancillary variables around it.
spk_0
Of course we try to optimize everything but optimization does not always mean this way or the
spk_0
other. It might be your way that you do it best for the patients. If you are doing general
spk_0
anesthesia and you keep the patients not moving and your complications rate with pneumonia and other
spk_0
things are not high and you don't drop the blood pressure during the procedure then go ahead and do it.
spk_0
If you do conscious sedation better and you say my dissections rates are not too high and
spk_0
I'm not going to have complications then go ahead and do it. That is actually help because people don't
spk_0
need to change their protocol and say well for 15 years I have been doing conscious sedation and
spk_0
now you're coming and telling me to go ahead and do general anesthesia of rarsers. Not at all.
spk_0
As long as you and your team are comfortable with the procedure there was no difference in this
spk_0
specific variable when it comes to outcomes. When it comes to limitations and why I want people to
spk_0
when they read or when they see something say I'm not sure I agree with this. Of course this is
spk_0
non-randomized. I have news for you. I highly doubt that you will ever have this question being
spk_0
randomized. I just spent five minutes talking to you about causation and association so you should
spk_0
not be asking this question again in this manner because it's unlikely that you will find this
spk_0
type of answer that maybe when you have larger sample size you would know better because you will
spk_0
have more power but I will have my reservations on the conclusions because this is clear to me at
spk_0
this point. The multitude of these insular variables would have some sort of effect but them individually
spk_0
is unlikely unless there is something that we are systematically doing that would result in derailing
spk_0
the patient's outcomes and we are finding from select two and from prior studies that actually
spk_0
start the case with evidence. You bring up a number of good points there but importantly even if
spk_0
there is some selection bias as long as people are selecting based on their level of skill and comfort
spk_0
in reprefusing the brain it's a really strong message from the entire body of this work which is that
spk_0
the brain even in the setting of large ischemic core large strokes refusing that brain cures a lot
spk_0
of ills and washes out a lot of other ways that we try to optimize patient care and that's an
spk_0
important message to take away. It's really what you learned early in your residency and what you
spk_0
will continue to teach residents verbally until we get to a point that stroke is a plot in the blood
spk_0
vessel prevents low to the brain and the mainstay wise is and will always be reprefusion.
spk_0
Opening the blood vessel beats not opening the blood vessels eight days a week. The other variables
spk_0
important the nursing care the other things absolutely but spending resources just the messages
spk_0
go ahead and perfect what you do best and you will have good results better results than
spk_0
medical management in this population. Valid point and as you say I tell my residents the students
spk_0
all the time the brain doesn't care how it gets blood flow back as long as it happens and you do it
spk_0
as safely and quickly as possible that's a main message to make it which and all this ongoing
spk_0
richness data that come out of extent IA and now the select research trials what am I going to
spk_0
be interviewing you about on the podcast next what excites you most about to the next steps and
spk_0
it's always wonderful to be with you Andy and to look at the future so we have done a lot of
spk_0
analysis from select to it to be worth mentioning we are up to the 16th or the 17th daybar.
spk_0
If you important points to highlight we looked at one year outcomes and this was published in
spk_0
Lancet and patients continue to improve you have 20% of the patients who continue to improve
spk_0
between nine to days and one year very important that you are patient with your patients. Scott
spk_0
Castner published a very nice paper on Nellies and Hemicrania versus Noemicrania in early
spk_0
withdrawal of care and patients do worse when we think they will do worse so give the patients
spk_0
opportunity you don't expect patients who have a perfusion of very large core to be running
spk_0
down the whole way on day to rehabilitation works it may take longer and actually it opens the
spk_0
door is do we need to do longer than three months or outcomes up to one year no difference in
spk_0
hemicrania versus no hemicrania so don't be shy if you needed to do hemicrania for these patients
spk_0
and reliefing the pressure and giving them an opportunity no difference between men and women
spk_0
very important message the frailty and the woman of older age you may predict worse outcomes this
spk_0
was not the case close effectiveness in different healthcare system and that's important
spk_0
to the health care systems to adapt this in the United States in Europe and Australia
spk_0
different imaging modalities CT aspects perfusion which we mentioned originally no difference so
spk_0
this is refreshing that this became as well guidelines may take a little bit of time this became
spk_0
part of the practice you and I can't attest to that time many people already change their
spk_0
because they see the evidence so next is we a few things that we still need to understand and
spk_0
to optimize things the treatment benefit and this population what was driven by a reperfusion
spk_0
part of it decreasing final and viral in part of it what is the role of cerebral edema what is
spk_0
one plus two plus three equals percentage of the improvement may not be from a single trial may
spk_0
need the collected collective data and it's good to share with your audience that the PIs for
spk_0
all the doctor randomized trials met agreed a few months ago to proceed with a meta-analysis
spk_0
of this population to shed light on the subgroups because there's no single trials power to
spk_0
tell you is it beneficial more than 150 you have a higher limit what about the Erlund versus
spk_0
Slate wonder even the question that we've just discussed about anesthesia and blood pressure and
spk_0
all of that so this data will be presented in its first shape at the World Stroke Conference in
spk_0
Barcelona next month the Atlas meta-analysis and will be again reread all of the images by
spk_0
independent core lab with Dr. Campbell and in Melbourne and then we'll probably represent the data
spk_0
and publish it to shed light and look at all of these subgroups how can we optimize the patients how
spk_0
can we enhance the outcomes for this population to get patients because this is why research is
spk_0
done it's not just to answer my curiosity or yours is to bring the questions that will bring a new
spk_0
treatment to patients and new populations to get patients back to their family into the society
spk_0
sound healthy and probably productive part of the society I believe that you're also going to be
spk_0
looking at patients who present after 24 hours from last know that is still an area where there's
spk_0
some echo poise these patients that present very late from time of last know correct me if I'm
spk_0
wrong this will be the select late trial that we're hoping to get off the ground and learn some from
spk_0
so for a long time we invest in nature of human being operated on having a line in the sand for
spk_0
time patients with TBA first three hours and four and a half hours from back to me first six hours
spk_0
than 24 hours but what about the population that may present beyond 24 hours and might still have
spk_0
viable brain tissue to be treated we're looking at this in this elect late trial and hopefully
spk_0
we partner on this with you in the population in the University of Virginia currently this is
spk_0
another uncharted territory so size is done what about late what about time can we open the door
spk_0
for those patients who may present two days from their last well more than 24 hours and if this
spk_0
shown to be positive and we published the cohorts multi center international study about this
spk_0
and showed potential benefit so we're known randomizing the patients if these patients would
spk_0
benefit this would change a lot this would change our assistance of care approach transfer
spk_0
and patients all of that but it's all would be for the good of the patients and yeah this might be
spk_0
a few years away it's a grant from the patient center to outcome and I'm really happy to
spk_0
partner with you and other colleagues on this to bring an answer to this important question
spk_0
fantastic that's a great message to end on and certainly sounds like there's a lot of ongoing
spk_0
collaboration that will lead even better analysis from these collective data within that atlus
spk_0
consortia and I will be excited to hear about that and perhaps we will bring you back on to tell
spk_0
us about that once it's presented at world's shirt congress next month but in the meantime I want
spk_0
to think again my colleague Amru Saraj for joining us with the podcast is discuss this paper again
spk_0
titled general versus non-general anesthesia for end of asco thrombone that to me and patients with
spk_0
large core strokes a pre-sumissified secondary analysis of the select to trial seek out the
spk_0
main paper in the neurology journal and look forward to this and other podcasts on the topic and
spk_0
really thank you so much again for joining us this is tacy claudier podcast editor if you've enjoyed
spk_0
the podcast please take a few moments to subscribe rate and review the neurology podcast through apple
spk_0
podcasts google podcast spotify or wherever you listen and remember you can always head to neurology.org
spk_0
exlash podcast for a full list of past episodes where you can also search by keyword in your podcast
spk_0
app running neurology specific topics you want to learn about